This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2016-2021.
Company Filing History:
Years Active: 2016-2021
Title: Masaki Sonoda: Innovator in Ophthalmic Solutions
Introduction
Masaki Sonoda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of ophthalmology, particularly through his innovative work on ophthalmic solutions. With a total of 4 patents to his name, Sonoda's inventions have the potential to enhance patient care and improve the effectiveness of eye treatments.
Latest Patents
Sonoda's latest patents focus on the development of Diquafosol ophthalmic solutions. His research addresses the challenges associated with the formation of insoluble precipitates during storage and the deterioration of filtration performance during production. By incorporating a chelating agent at a concentration of 0.0001 to 1% (w/v), his inventions have demonstrated a reduction in eye irritation and an enhancement of preservative effectiveness compared to solutions without the chelating agent. These advancements ensure that the physicochemical properties of the ophthalmic solutions remain stable throughout production, distribution, and patient storage.
Career Highlights
Sonoda is affiliated with Santen Pharmaceutical Co., Ltd., a leading company in the field of ophthalmology. His work has not only contributed to the company's innovative portfolio but has also positioned him as a key figure in the development of effective eye care solutions.
Collaborations
Throughout his career, Sonoda has collaborated with notable colleagues, including Masatsugu Nakamura and Yoko Fukui. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Masaki Sonoda's contributions to ophthalmic solutions exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving patient outcomes and advancing the field of ophthalmology.